Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the formation of biologically active compounds that target specific signaling pathways in tumor cells. Commonly employed in medicinal chemistry for constructing pyrrolopyridine-based drug candidates due to its reactivity and functional group compatibility. Also utilized in research settings for generating analogs in structure-activity relationship (SAR) studies.